We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FREEW
376
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$77.4K ﹤0.01%
336,653
SCRMW
377
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$70.7K ﹤0.01%
299,997
PUCKW
378
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$52.7K ﹤0.01%
1,090,799
TWOA
379
DELISTED
two
TWOA
$51.9K ﹤0.01%
+5,157
New +$51.5K
GFX.WS
380
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$42.7K ﹤0.01%
284,575
GIACW
381
DELISTED
Gesher I Acquisition Corp. Warrants
GIACW
$37.5K ﹤0.01%
+74,998
New +$35.2K
AISPW
382
Airship AI Holdings Warrants
AISPW
$16.2M
$34K ﹤0.01%
+425,000
New +$16.2K
AAC.WS
383
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$27.2K ﹤0.01%
+58,261
New +$11.4K
HPX.WS
384
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$26.3K ﹤0.01%
62,499
ADERW
385
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$25K ﹤0.01%
100,000
BTMDW
386
DELISTED
Biote Corp. Warrant
BTMDW
$25K ﹤0.01%
99,997
NAMSW icon
387
NewAmsterdam Pharma Warrant
NAMSW
$78.2M
$25K ﹤0.01%
+31,189
New +$25.7K
QSIAW
388
DELISTED
Quantum-Si Inc Warrant
QSIAW
$21.6K ﹤0.01%
86,598
JCICW
389
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$21K ﹤0.01%
100,000
+11,750
+13% +$2.55K
PNTM.WS
390
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$17.9K ﹤0.01%
223,577
CPUH.WS
391
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$15.7K ﹤0.01%
140,088
MVLAW
392
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$14.5K ﹤0.01%
93,251
CIIGW
393
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$14K ﹤0.01%
+199,999
New +$13.2K
SNRHW
394
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$12.3K ﹤0.01%
205,151
ECXWW
395
ECARX Holdings Warrants
ECXWW
$12.3K ﹤0.01%
+124,999
New +$9.72K
FLDDW
396
Fold Holdings Warrant
FLDDW
$948K
$11.6K ﹤0.01%
+232,918
New +$13.1K
GROV.WS
397
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$11.4K ﹤0.01%
113,509
SLAMW
398
DELISTED
Slam Corp. warrant
SLAMW
$10.7K ﹤0.01%
121,866
ML.WS
399
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$10.3K ﹤0.01%
249,998
TBCPW
400
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$10.1K ﹤0.01%
132,047

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.